- €12.77bn
- -€14.96bn
- €5.20bn
- 64
- 92
- 96
- 98
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 7.15 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | -14.6% | ||
| Dividend Yield (f) | 7.14% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.83 | ||
| Price to Tang. Book | 0.88 | ||
| Price to Free Cashflow | 4.03 | ||
| Price to Sales | 2.46 | ||
| EV to EBITDA | -50.71 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 1.91% | ||
| Return on Equity | 14.91% | ||
| Operating Margin | 52.01% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 2,604 | 2,571 | 3,134 | 4,938 | 5,195 | 4,423.99 | 4,391.48 | 12.21% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | -2.07 | +176.17 | +17.49 | -20.52 | +2.89 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
AIB Group PLC is an Ireland-based financial services company. The Company's segments include Retail Banking, AIB Capital Markets (Capital Markets), AIB UK, Climate Capital, and Group. The Retail Banking segment comprises Homes & Consumer, small and medium enterprise (SME). The Capital Markets segment provides institutional, corporate and business banking services to its larger customers and customers requiring specific sector or product expertise. Capital Markets offers customers foreign exchange and interest rate risk management products, cash management products, trade finance, mezzanine finance, and equity investments. The AIB UK segment offers corporate, retail and business banking services in two distinct markets, such as a sector-led corporate bank and a full-service retail bank. The Climate Capital specializes in lending to large scale renewable energy and infrastructure projects. The Group segment comprises wholesale treasury activities and Group control and support functions.
Directors
- Jim Pettigrew NEC
- Colin Hunt CEO (50)
- Brendan McDonagh NVC (61)
- Donal Galvin CFO (47)
- CJ Berry COO
- Geraldine Casey CHO
- Fergal Coburn CTO
- Deirdre Hannigan CRO (59)
- Helen Dooley GCN (51)
- Cathy-Ann Bryce MDR
- Robert Mulhall MDR (46)
- Jim O' Keeffe MDR (52)
- Mary Whitelaw OTH
- Anik Chaumartin NID (60)
- Basil Geoghegan NID
- Tanya Horgan NID
- Carolan Lennon NID (53)
- Elaine MacLean NID
- Andy Maguire NID (53)
- Helen Normoyle NID (52)
- Ann O'Brien NID
- Fergal O'Dwyer NID
- Sandy Pritchard NID
- Jan Sijbrand NID (67)
- Ranjit Singh NID (67)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 8th, 2016
- Public Since
- June 23rd, 2017
- No. of Employees
- 10,469
- Sector
- Banking Services
- Industry
- Financials
- Exchange
Irish Stock Exchange- Shares in Issue
- 2,328,438,575
- Address
- 10 Molesworth Street, Dublin 2, DUBLIN
- Web
- https://aib.ie/group
- Phone
- +353 17725861
- Auditors
- PricewaterhouseCoopers
Latest News for A5G
Upcoming Events for A5G
AIB Group PLC Annual Shareholders Meeting
Q1 2025 AIB Group PLC Trading Statement Release
AIB Group plc Annual Shareholders Meeting
Half Year 2025 AIB Group PLC Earnings Release
Similar to A5G
Bank of Ireland
Irish Stock Exchange
Permanent TSB group
Irish Stock Exchange
FAQ
As of Today at 19:07 UTC, shares in AIB are trading at €5.49. This share price information is delayed by 15 minutes.
Shares in AIB last closed at €5.49 and the price had moved by +10.14% over the past 365 days. In terms of relative price strength the AIB share price has outperformed the FTSE Global All Cap Index by +5.81% over the past year.
The overall consensus recommendation for AIB is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe AIB dividend yield is 6.74% based on the trailing twelve month period.
Last year, AIB paid a total dividend of €0.37, and it currently has a trailing dividend yield of 6.74%.Looking ahead, the next dividend pay date is 2025-05-09.
We do not have data on when AIB is to next pay dividends. The historic dividend yield on AIB shares is currently 6.74%.
To buy shares in AIB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €5.49, shares in AIB had a market capitalisation of €12.77bn.
Here are the trading details for AIB:
- Country of listing: Ireland
- Exchange: ISE
- Ticker Symbol: A5G
Based on an overall assessment of its quality, value and momentum AIB is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in AIB is €6.80. That is 23.97% above the last closing price of €5.49.
Analysts covering AIB currently have a consensus Earnings Per Share (EPS) forecast of €0.76 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like AIB. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +13.19%.
As of the last closing price of €5.49, shares in AIB were trading -0.57% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The AIB PE ratio based on its reported earnings over the past 12 months is 7.15. The shares last closed at €5.49.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
AIB's management team is headed by:
- Jim Pettigrew - NEC
- Colin Hunt - CEO
- Brendan McDonagh - NVC
- Donal Galvin - CFO
- CJ Berry - COO
- Geraldine Casey - CHO
- Fergal Coburn - CTO
- Deirdre Hannigan - CRO
- Helen Dooley - GCN
- Cathy-Ann Bryce - MDR
- Robert Mulhall - MDR
- Jim O' Keeffe - MDR
- Mary Whitelaw - OTH
- Anik Chaumartin - NID
- Basil Geoghegan - NID
- Tanya Horgan - NID
- Carolan Lennon - NID
- Elaine MacLean - NID
- Andy Maguire - NID
- Helen Normoyle - NID
- Ann O'Brien - NID
- Fergal O'Dwyer - NID
- Sandy Pritchard - NID
- Jan Sijbrand - NID
- Ranjit Singh - NID